Chapter 11: Challenges in and Principles for Conducting Systematic Reviews of Genetic Tests used as Predictive Indicators

[1]  J. Paulauskis,et al.  So Many Studies, Too Few Subjects: Establishing Functional Relevance of Genetic Polymorphisms on Pharmacokinetics , 2006, Journal of clinical pharmacology.

[2]  J. Little,et al.  N-acetyltransferase polymorphisms and colorectal cancer: a HuGE review. , 2000, American journal of epidemiology.

[3]  N. Aronson,et al.  HER2 testing to manage patients with breast cancer or other solid tumors. , 2008, Evidence report/technology assessment.

[4]  M. McCarthy,et al.  Genome-wide association studies for complex traits: consensus, uncertainty and challenges , 2008, Nature Reviews Genetics.

[5]  Brian F. Gage,et al.  Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues , 2008, Journal of Thrombosis and Thrombolysis.

[6]  R. Hayes,et al.  Self-collection of oral epithelial cell DNA under instruction from epidemiologic interviewers. , 2000, American journal of epidemiology.

[7]  J. Haddow,et al.  Updated assessment of cystic fibrosis mutation frequencies in non-Hispanic Caucasians , 2002, Genetics in Medicine.

[8]  N. Caporaso.  Selection of candidate genes for population studies. , 1999, IARC scientific publications.

[9]  Howard L McLeod,et al.  Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin , 2003, Thrombosis and Haemostasis.

[10]  W. Grody,et al.  Estimated analytic validity of HFE C282Y mutation testing in population screening: The potential value of confirmatory testing , 2003, Genetics in Medicine.

[11]  D. Nickerson,et al.  Single-well genotyping of diallelic sequence variations by a two-color ELISA-based oligonucleotide ligation assay. , 1996, Nucleic acids research.

[12]  Eileen Erinoff,et al.  Addressing Challenges in Genetic Test Evaluation: Evaluation Frameworks and Assessment of Analytic Validity , 2011 .

[13]  S. Grundy,et al.  National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .

[14]  Atul Wad,et al.  Technology assessment , 1984 .

[15]  P. Vineis.  Metabolic Polymorphisms and Susceptibility to Cancer , 1999 .

[16]  Daniel E Jonas,et al.  Genetic and clinical factors relating to warfarin dosing. , 2009, Trends in pharmacological sciences.

[17]  Ludwig A Hothorn,et al.  Data Supplement (unedited) at: , 2007 .

[18]  C. Hoggart,et al.  Genome‐wide significance for dense SNP and resequencing data , 2008, Genetic epidemiology.

[19]  C. R. Connell,et al.  Allelic discrimination by nick-translation PCR with fluorogenic probes. , 1993, Nucleic acids research.

[20]  A. Guttmacher,et al.  Genetic test evaluation: information needs of clinicians, policy makers, and the public. , 2002, American journal of epidemiology.

[21]  Quanhe Yang,et al.  5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. , 2000, American journal of epidemiology.

[22]  K. Buetow,et al.  Collection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwash. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[23]  C. Richards,et al.  Analytic validity of cystic fibrosis testing: A preliminary estimate , 2003, Genetics in Medicine.

[24]  P. Harper,et al.  Promoting safe and effective genetic testing in the United States: Final Report of the Task Force on Genetic Testing. , 1998, Community genetics.

[25]  U. P. S. T. Force.  Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Recommendation Statement , 2005, Annals of Internal Medicine.

[26]  Ammarin Thakkinstian,et al.  How to use an article about genetic association: B: Are the results of the study valid? , 2009, JAMA.

[27]  Ammarin Thakkinstian,et al.  How to use an article about genetic association: A: Background concepts. , 2009, JAMA.

[28]  Y. Benjamini,et al.  Controlling the false discovery rate in behavior genetics research , 2001, Behavioural Brain Research.

[29]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[30]  John R Thompson,et al.  Biostatistical Aspects of Genome‐Wide Association Studies , 2008, Biometrical journal. Biometrische Zeitschrift.

[31]  M. Khoury,et al.  The Human Genome Epidemiology Network. , 1998, American journal of epidemiology.

[32]  K. Hall,et al.  Improved procedure for eluting DNA from dried blood spots. , 1996, Clinical chemistry.

[33]  B. Wessler,et al.  Genetic Tests for Cancer , 2006 .

[34]  Holtzman Na,et al.  Promoting safe and effective genetic testing in the United States. Final report of the Task Force on Genetic Testing. , 1999, Journal of child and family nursing.

[35]  S. Teutsch,et al.  The evaluation of genomic applications in practice and prevention (EGAPP) initiative , 2009 .

[36]  Nathaniel Rothman,et al.  Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. , 2004, Journal of the National Cancer Institute.

[37]  A R Feinstein,et al.  Clinical epidemiological quality in molecular genetic research: the need for methodological standards. , 1999, JAMA.

[38]  J. Little,et al.  Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review. , 2000, American journal of epidemiology.

[39]  T. Rebbeck,et al.  Collection of genomic DNA by buccal swabs for polymerase chain reaction-based biomarker assays. , 1999, Environmental health perspectives.

[40]  D. T. Vernier,et al.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.

[41]  C. Weinberg,et al.  Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. , 2002, American journal of epidemiology.

[42]  W. Baine,et al.  The Agency for Healthcare Research and Quality , 2006, Italian Journal of Public Health.

[43]  C. Bunker,et al.  HLA-DQ locus of the human leukocyte antigen complex and type 1 diabetes mellitus: a HuGE review. , 2000, Epidemiologic reviews.

[44]  C. Mulrow,et al.  Current methods of the US Preventive Services Task Force: a review of the process. , 2001, American journal of preventive medicine.

[45]  Ronald M. Lauer,et al.  National Cholesterol Education Program. Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction: executive summary. National Heart, Lung and Blood Institute, National Institutes of Health. , 1991, Archives of internal medicine.

[46]  P Boffetta,et al.  Review of studies of selected metabolic polymorphisms and cancer. , 1999, IARC scientific publications.

[47]  David B Matchar,et al.  Testing for cytochrome P450 polymorphisms in adults with non-psychotic depression treated with selective serotonin reuptake inhibitors (SSRIs). , 2007, Evidence report/technology assessment.

[48]  B. Belkhouche,et al.  Acknowledgements We Would like to Thank , 1993 .

[49]  M. Greaves,et al.  Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[50]  S. Teutsch,et al.  The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group , 2009, Genetics in Medicine.

[51]  E. Harris,et al.  Screening for Hereditary Hemochromatosis: A Systematic Review for the U.S. Preventive Services Task Force , 2006, Annals of Internal Medicine.

[52]  Rongwei Fu,et al.  Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Systematic Evidence Review for the U.S. Preventive Services Task Force , 2005, Annals of Internal Medicine.

[53]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.